Paper: Radiomics in Oncology: A 10-Year Bibliometric Analysis
“This paper recognize our pioneer role in the field of radiomics “With the most citations of the 10 leading co-cited authors, Philippe Lambin (from the Dpt […]
Our first paper on CP-506, a new Hypoxia-activated prodrug (HAP) is published.
CP-506 can selectively eliminate hypoxic tumor cells. In our hands, CP-506 has several advantages compared to the previous HAP’s (see for example the very step curve […]
Our Nature Cancer paper on MEDomics: :
https://www.nature.com/articles/s43018-021-00236-2.epdf?sharing_token=KgtCNNhfYIHSXAlRKDoRwNRgN0jAjWel9jnR3ZoTv0PaqzLmM-RKhUiVyn1ERuyoe5QEvjLDx4PnnREswcxiagrd3l54oTv-p25UKrRkN2DnUQEtHvlBkjNcX3cQYh-h_QOBrEHxAwuhXjwtvB_FIVE3h1ifEb8mGMw8Olb2C20%3D
New paper on HNSCC
Our paper on combined prognostic signatures (clinical, biology, radiomics variables) on Head and Neck Cancer stage III-IVA is out (n=666 retrospective + 143 prospective patients, p<0.01, […]
Our article “Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an In Silico Clinical Trial and a Cost–Utility Study”
Our article “Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an In Silico Clinical Trial and a Cost–Utility Study” […]
Brightlands, Maastricht Health Campus
Eureka Today, Expert: Jan Theys In 1996 Jan Theys started his research as a PhD student in Leuven. In short: he uses the non-pathogenic bacterium Clostridium […]
Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis
Read the article on our ERC grant “Clostridium-based Immunotherapy” which has been published on the CORDIS website in six languages at: https://lnkd.in/g5AQSvR
Bijna twee miljoen euro voor kankeronderzoek in het Maastricht UMC+
Is schildklierkanker te ruiken in uitademingslucht? Zijn bacteriën naar tumoren te sturen om daar medicijnen te produceren? KWF Kankerbestrijding investeert 1,8 miljoen euro in 3 onderzoeken […]
Obtaining research grants in times of corona
https://www.maastrichtuniversity.nl/news/obtaining-research-grants-times-corona
- https://www.maastrichtuniversity.nl/news/obtaining-research-grants-times-corona
- podcast https://www.birpublications.org/page/podcasts/2020/bjr125-radiomics.
- press release: https://www.prnewswire.com/news-releases/the-department-of-precision-medicine-of-maastricht-university-receives-920k-from-the-european-commission-to-further-develop-their-work-on-artificial-intelligence-tools-for-covid-19-patients-301058567.html?tc=eml_cleartime
- Kunstmatige intelligentie in de oncologie 2020- Pagina 13
- ERC Proof of concept for Philippe Lambin https://www.maastrichtuniversity.nl/news/erc-proof-concept-grant-development-and-testing-ai-software-lung-cancer
- DRAGON article in Trends Tendance
- Interview Jan Theys – gebruik van de niet-pathogene bacterie Clostridium voor het ‘transport’ van een chemotherapeuticum naar de tumor.
- Ludwig Dubois – DE ROL VAN OMGEVINGSFACTOREN OP HET ONTSTAAN VAN KANKER EN DE LEVENSKWALITEIT VAN KANKERPATIËNTEN.